Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Oxygenta PharmaceuticalBOM:524636 +6.13%42 Days Inventory is 88.76 as of Jun. 2026, which is 28% above its 10-year median of 69.55. GuruFocus rates BOM:524636 with a GF Score™ of 42/100 and a GF Value™ of ₹84.23 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 923 Drug Manufacturers companies, Oxygenta Pharmaceutical ranks better than 88.19% on this metric.
The historical rank and industry rank for Oxygenta Pharmaceutical's Days Inventory or its related term are showing as below:
BOM:524636'
s Days Inventory Range Over the Past 10 Years
Min: 50.79 Med: 69.55 Max: 113.33
Current: 74.98
During the past 13 years, Oxygenta Pharmaceutical's highest Days Inventory was 113.33. The lowest was 50.79. And the median was 69.55.
BOM:524636's Days Inventory is ranked better than 88.19% of 923
companies
in the Drug Manufacturers industry
Industry Median: 164.87
vs BOM:524636: 74.98
Oxygenta Pharmaceutical's Days Inventory
declined
from Jun. 2025 (125.16) to Jun. 2026 (88.76).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Oxygenta Pharmaceutical's Inventory Turnover for the
three
months ended in Jun. 2026 was 1.03.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Oxygenta Pharmaceutical's Inventory-to-Revenue for the
three
months ended in Jun. 2026 was 0.80.
Oxygenta Pharmaceutical (BOM:524636) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Oxygenta Pharmaceutical's Inventory Turnover for the
three
months ended in Jun. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Oxygenta Pharmaceutical's Inventory to Revenue for the
three
months ended in Jun. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Oxygenta Pharmaceutical Days Inventory Related Terms
Oxygenta Pharmaceutical Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Oxygenta Pharmaceutical's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Oxygenta Pharmaceutical Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Oxygenta Pharmaceutical's Days Inventory distribution charts can be found below:
* The bar in red indicates where Oxygenta Pharmaceutical's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Oxygenta Pharmaceutical (BOM:524636) has a Days Inventory of 88.76 as of Jun. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Oxygenta Pharmaceutical and its competitors. This is 28% above median its historical median of 69.55. Over the past decade, Oxygenta Pharmaceutical's Days Inventory has ranged from 50.79 to 113.33. According to the industry distribution chart, Oxygenta Pharmaceutical ranks #109 out of 923 companies in the Drug Manufacturers industry, placing it in the top 11.8%.
Is Oxygenta Pharmaceutical's Days Inventory too high?
Oxygenta Pharmaceutical's current Days Inventory of 88.76 is 28% above median its 10-year median of 69.55. Over the past 10 years, this metric has ranged from a low of 50.79 to a high of 113.33. The Drug Manufacturers industry median Days Inventory is 164.87. Oxygenta Pharmaceutical's value of 88.76 is 46.2% below this industry median. Based on the distribution chart, Oxygenta Pharmaceutical ranks #109 out of 923 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Oxygenta Pharmaceutical has a GF Score™ of 42/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Oxygenta Pharmaceutical's Days Inventory compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Oxygenta Pharmaceutical ranks #109 out of 923 companies for Days Inventory. This places Oxygenta Pharmaceutical in the top 12% of its industry — outperforming the majority of peers. The industry median Days Inventory is 164.87. Oxygenta Pharmaceutical's value of 88.76 is 46.2% below this benchmark. Historically, Oxygenta Pharmaceutical's own Days Inventory has ranged from 50.79 to 113.33 over the past decade. While the company's 10-year median is 69.55 vs. the industry median of 164.87, Oxygenta Pharmaceutical has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.87, based on 923 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Oxygenta Pharmaceutical's current Days Inventory of 88.76 is 46.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Oxygenta Pharmaceutical and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Oxygenta Pharmaceutical's current Days Inventory is 88.76, which is 28% above median its own 10-year median of 69.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Oxygenta Pharmaceutical stock overvalued right now?
Based on GuruFocus' analysis, Oxygenta Pharmaceutical (BOM:524636) is currently considered Possible Value Trap. The stock's GF Value™ is ₹84.23, compared to a current price of ₹51.25 — trading 39.2% below its estimated fair value. The current Days Inventory is 88.76, which is 28% above median its 10-year median of 69.55 and 46.2% below the Drug Manufacturers industry median of 164.87. Oxygenta Pharmaceutical's overall GF Score™ is 42/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Oxygenta Pharmaceutical (BOM:524636), the current Days Inventory is 88.76 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Oxygenta Pharmaceutical (BOM:524636) Overvalued in 2026?
Based on GuruFocus' analysis, Oxygenta Pharmaceutical stock appears to be undervalued.
The current stock price of ₹51.25 is trading 39.2% below its estimated GF Value™ of ₹84.23.
GuruFocus considers Oxygenta Pharmaceutical to be Possible Value Trap.
Key valuation signals for BOM:524636:
Days Inventory: 88.76 (28% above median its 10-year median of 69.55)
GF Value™: ₹84.23 vs. price of ₹51.25 (39.2% below fair value)
Industry Position: 46.2% below the Drug Manufacturers median (#109 of 923)
No single metric tells the full story. See the BOM:524636 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Oxygenta Pharmaceutical Ltd is a pharmaceutical company. It is engaged in the business activity of is engaged in manufacturing and selling of Pharmaceutical, medical, and veterinary preparations. The Company has one reportable segment, which is Pharmaceutical. The group carries out its business operations within India.
42GF Score
Get the complete analysis for BOM:524636
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:524636 has been successfully added to your 
